Skip to main content
. 2022 Apr 20;9(1):e001900. doi: 10.1136/openhrt-2021-001900

Table 3.

Adjusted HRs with 95% CIs for the risk of all-cause and cardiovascular mortality associated with statin use stratified by sex

Whole population (n=17 262) Women (n=8981) Men (n=8281)
All-cause mortality (nevent=1035)
No statin (ref) 1 1 1
Statin 0.76 (0.71 to 0.82) 0.66 (0.58 to 0.74) 0.89 (0.81 to 0.96)
Cardiovascular mortality (nevent=270)
No statin (ref) 1 1 1
Statin 0.72 (0.61 to 0.83) 0.55 (0.39 to 0.71) 0.93 (0.77 to 1.08)